Who Exports Cephalexin from India — 223 Suppliers Behind a $349.5M Market
India's cephalexin export market is supplied by 223 active exporters who collectively shipped $349.5M across 5,117 shipments. ALKEM LABORATORIES LIMITED leads with a 69.4% market share, followed by LUPIN LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 88.9% of total export value, reflecting a concentrated market structure.
Top Cephalexin Exporters from India — Ranked by Export Value
ALKEM LABORATORIES LIMITED is the leading cephalexin exporter from India, holding a 69.4% share of the $349.5M market across 5,117 shipments from 223 exporters. The top 5 suppliers — ALKEM LABORATORIES LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED — collectively control 88.9% of total export value, indicating a highly concentrated market. Individual shares are: ALKEM LABORATORIES LIMITED (69.4%), LUPIN LIMITED (10.2%), AUROBINDO PHARMA LTD (3.4%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.0%), CIPLA LIMITED (2.8%).
Top Cephalexin Exporters from India
Ranked by export value · 223 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LIMITED CEPHALEXIN 500MG CAPSULES - 3103 PAC X 500'SCEPHALEXIN 500MG CAPSULES [1527 PACK X 500'S=763500 CAP] | $242.6M | 3 | 69.4% |
| 2 | LUPIN LIMITED CEPHALEXIN 500MG CAPSULES - 3103 PAC X 500'SCEPHALEXIN 500MG CAPSULES [1527 PACK X 500'S=763500 CAP]APO-CEPHALEXIN CAP 500MG PACK:BOX20S BAT | $35.7M | 7 | 10.2% |
| 3 | AUROBINDO PHARMA LTD CEPHALEXIN 500MG CAPSULES - 3103 PAC X 500'SCEPHALEXIN 500MG CAPSULES [1527 PACK X 500'S=763500 CAP]CEPHALEXIN TABLETS 500 MG (AURO-CEPHALEX | $11.8M | 5 | 3.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATORIPHEX 250MG CAPS (CEPHALEXIN MONOHYDRACEPHALEXIN GENERIC HEALTH CAPS 500MG CEP | $10.6M | 10 | 3.0% |
| 5 | CIPLA LIMITED CEPHADEX 500 CAPS .CEPHAST 500MGCEPHAST DRY SYRUP(CEPHALEXIN ORAL SUSPEN | $9.9M | 3 | 2.8% |
| 6 | STERLING LAB, CEPHADEX 500 CAPS .CEPHAST 500MGCEPHAST DRY SYRUP(CEPHALEXIN ORAL SUSPEN | $7.6M | 1 | 2.2% |
| 7 | WEXFORD LABORATORIES PRIVATE LIMITED CEPHALEXIN CAPSULES BP 500MGCEPHALEXIN ORAL SUSPENSION USP 250MG/5MLCEPHALEXIN CAPSULES USP 500 M G | $5.7M | 1 | 1.6% |
| 8 | SANCE LABORATORIES PRIVATE LIMITED SANCEPH-250 CAP CEPHALEXIN CAPSULES USP250MGORIPHEX 250MG CAPS (CEPHALEXIN MONOHYDRACEPHALEXIN CAPSULES 500MG (AUROCEF 500 ( | $4.0M | 8 | 1.1% |
| 9 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $3.4M | 2 | 1.0% |
| 10 | AUROBINDO PHARMA LIMITED CEPHALEXIN 500MG CAPSULES - 3103 PAC X 500'SCEPHALEXIN 500MG CAPSULES [1527 PACK X 500'S=763500 CAP]CEPHALEXIN TABLETS 500 MG (AURO-CEPHALEX | $3.0M | 4 | 0.9% |
| 11 | BRAWN LABORATORIES LIMITED SANCEPH-250 CAP CEPHALEXIN CAPSULES USP250MGORIPHEX 250MG CAPS (CEPHALEXIN MONOHYDRACEPHALEXIN CAPSULES 500MG (AUROCEF 500 ( | $2.3M | 12 | 0.7% |
| 12 | SCOTT EDIL PHARMACIA LIMITED CEPHALEXIN CAPSULES BP 500MGCEPHALEXIN ORAL SUSPENSION USP 250MG/5MLSANCEPH-250 CAP CEPHALEXIN CAPSULES USP250MG | $2.2M | 6 | 0.6% |
| 13 | SANJIVANI PARANTERAL LIMITED | $1.0M | 1 | 0.3% |
| 14 | ZYDUS LIFESCIENCES LIMITED ORIPHEX 250MG CAPS (CEPHALEXIN MONOHYDRAORIPHEX 250MG CAPS CEPHALEXIN MONOHYDRATE 10X10ORIPHEX 250MG CAPS 10X10 | $770.8K | 3 | 0.2% |
| 15 | ALKEM LABORATORIES LTD CEPHALEXIN 500MG CAPSULES - 3103 PAC X 500'SCEPHALEXIN 500MG CAPSULES [1527 PACK X 500'S=763500 CAP] | $672.0K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cephalexin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Alkem Laboratories Limited | Approved | Yes | Yes | Multiple | Alkem has received multiple FDA approvals and holds WHO-GMP and EU GMP certifica |
| Lupin Limited | Approved | Yes | Yes | Multiple | Lupin has received multiple FDA approvals and holds WHO-GMP and EU GMP certifica |
| Aurobindo Pharma Limited | Approved | Yes | Yes | Multiple | Aurobindo has received multiple FDA approvals and holds WHO-GMP and EU GMP certi |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | Multiple | Sun Pharma has received multiple FDA approvals and holds WHO-GMP and EU GMP cert |
| Cipla Limited | Approved | Yes | Yes | Multiple | Cipla has received multiple FDA approvals and holds WHO-GMP and EU GMP certifica |
| Sterling Lab | Not Listed | Yes | No | Not Listed | Sterling Lab holds WHO-GMP certification but lacks FDA approval and EU GMP certi |
| Wexford Laboratories Private Limited | Not Listed | Yes | No | Not Listed | Wexford Laboratories holds WHO-GMP certification but lacks FDA approval and EU G |
| Sance Laboratories Private Limited | Not Listed | Yes | No | Not Listed | Sance Laboratories holds WHO-GMP certification but lacks FDA approval and EU GMP |
| Biomatrix Healthcare Private Limited | Not Listed | Yes | No | Not Listed | Biomatrix Healthcare holds WHO-GMP certification but lacks FDA approval and EU G |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | Zydus has received multiple FDA approvals and holds WHO-GMP and EU GMP certifica |
TransData Nexus reviewed the regulatory standing of 10 leading Cephalexin exporters from India. 6 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 6 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cephalexin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies, including Aurobindo Pharma Limited, which is headquartered in Hyderabad. Aurobindo Pharma is a significant contributor to India's Cephalexin exports, accounting for $11.8 million (3.4%) of the total exports between 2022 and 2026.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to major pharmaceutical companies such as Zydus Lifesciences Limited, headquartered in Ahmedabad. Gujarat contributes nearly 28% of India's pharmaceutical production, with Vadodara being a significant hub for pharmaceutical industries.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region in Maharashtra serves as a critical export gateway for pharmaceuticals. This area houses the headquarters of industry giants like Alkem Laboratories Limited, which is based in Mumbai. Alkem Laboratories is the leading exporter of Cephalexin from India, contributing $242.6 million (69.4%) to the total exports between 2022 and 2026.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, largely due to favorable tax incentives and government policies. Baddi is home to over 1,000 pharmaceutical manufacturing units, making it Asia's largest pharmaceuticals hub. The region contributes significantly to India's pharmaceutical exports, with companies like Cipla Limited operating manufacturing plants in Baddi.
5Sourcing Recommendations
- Diversify Supplier Base: While Alkem Laboratories Limited is the dominant exporter of Cephalexin, accounting for 69.4% of exports, it's prudent to engage with other suppliers such as Lupin Limited and Aurobindo Pharma Limited to mitigate supply chain risks.
- Leverage Regional Specializations: Utilize the strengths of different pharmaceutical clusters. For instance, source APIs from Hyderabad and formulations from the Ahmedabad-Vadodara region to optimize quality and cost.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international regulatory standards, especially when sourcing from regions like Baddi-Nalagarh, which have rapidly expanded due to tax incentives.
- Assess Logistics and Export Capabilities: Given the strategic location of the Mumbai-Thane-Raigad region as an export gateway, consider suppliers in this area for efficient international distribution.
By strategically engaging with suppliers across these key pharmaceutical clusters, TransData Nexus can enhance the resilience and efficiency of its Cephalexin supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Cephalexin exporters from India
Lupin Limited — Lupin acquires French pharmaceutical company Medisol
In May 2023, Lupin Limited announced the acquisition of Medisol, a French pharmaceutical company, aiming to strengthen its presence in the European market. - IMPACT: This acquisition is expected to enhance Lupin's production capabilities, potentially increasing Cephalexin exports to Europe.
Impact: This acquisition is expected to enhance Lupin's production capabilities, potentially increasing Cephalexin exports to Europe.
Aurobindo Pharma Limited — Aurobindo's TheraNym partners with Merck for biologics manufacturing
In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: While focused on biologics, this collaboration may indirectly benefit Aurobindo's overall manufacturing efficiency, potentially impacting Cephalexin production.
Impact: While focused on biologics, this collaboration may indirectly benefit Aurobindo's overall manufacturing efficiency, potentially impacting Cephalexin production.
Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care business
In April 2024, Cipla Limited acquired the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, aiming to diversify its product portfolio. - IMPACT: This diversification may lead to resource reallocation, potentially affecting Cephalexin export volumes.
Impact: This diversification may lead to resource reallocation, potentially affecting Cephalexin export volumes.
Common Questions — Cephalexin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cephalexin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ALKEM LABORATORIES LIMITED leads with 618 recorded shipments worth $242.6M. LUPIN LIMITED (601 shipments) and AUROBINDO PHARMA LTD (242 shipments) are also established high-volume exporters.
Q How many cephalexin manufacturers are there in India?
India has 223 active cephalexin exporters with a combined export market of $349.5M across 5,117 shipments to 104 countries. The top 5 suppliers hold 88.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cephalexin from India?
Average FOB unit price: $6.22 per unit, ranging from $0.01 to $2346.45. Average shipment value: $68.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 223 verified Indian exporters of Cephalexin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,117 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 104 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,117 Verified Shipments
223 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists